APPLICATION
ANDA202298
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-19
LATEST ACTION
2019-10-11
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
GLIPIZIDEDiscontinued
GLIPIZIDE 5MG · TABLET, EXTENDED RELEASE · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 10MG · TABLET, EXTENDED RELEASE · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 2.5MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2019-10-11Labeling · Supplement 6 · standardAP
2019-10-11Labeling · Supplement 4 · standardAP
2016-04-18Labeling · Supplement 3 · standardAP
2015-05-19OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.